1996
DOI: 10.1016/s0278-6915(96)00060-9
|View full text |Cite
|
Sign up to set email alerts
|

Subacute toxicity of ergometrine maleate in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 10 publications
0
8
0
Order By: Relevance
“…Enlarged livers have been associated with increased hepatocellular glycogen storage in rats fed diets containing up to 250 mg ergometrine maleate/kg for four weeks [15], or 20–500 mg ergocryptine/kg for 28–32 days [16,17]. As no histopathology was performed in the present experiment the nature of the hepatomegalia needs to be examined further.…”
Section: Discussionmentioning
confidence: 99%
“…Enlarged livers have been associated with increased hepatocellular glycogen storage in rats fed diets containing up to 250 mg ergometrine maleate/kg for four weeks [15], or 20–500 mg ergocryptine/kg for 28–32 days [16,17]. As no histopathology was performed in the present experiment the nature of the hepatomegalia needs to be examined further.…”
Section: Discussionmentioning
confidence: 99%
“…Earlier findings revealed that ergot alkaloids affected the nutrient status of the liver [2,3,4]. Moreover, hepatic CYP metabolism of and induction by ergot alkaloids have been demonstrated [5,6].…”
Section: Discussionmentioning
confidence: 99%
“…Besides their pharmacological potential, ergot alkaloids are also capable of influencing the liver, the organ exposed to these substances via the portal vein directly after absorption from the gastro-intestinal tract. The liver is involved in xenobiotic metabolism and was shown to respond to ergocryptine and ergometrine maleate with an increased liver weight and an altered glycogen metabolism of rats [2,3,4]. Moreover, the xenobiotic metabolizing enzymes of the cytochrome P450 (CYP) family were demonstrated to be involved in ergot metabolism [5] and to be induced [6].…”
Section: Introductionmentioning
confidence: 99%
“…EAs are mycotoxins that interact agonistically with monoamine receptors such as dopamine receptors and adversely affect the cardiovascular, nervous, reproductive and immune system of humans and animals 124–132. Reports on EA‐induced adverse effects include safety studies in animal models with selected EAs 127–130, a report on field outbreaks of EA toxicity in cattle resulting in loss of milk production, loss of body mass and reduced fertility 131 as well as a human intoxication reporting myocardial infarction upon prolonged therapeutic use of ergotamine 132. Pharmaceutically, ergotamine tartrate is used in the treatment of migraine.…”
Section: Alkaloids Derived From Tryptophanmentioning
confidence: 99%
“…For example, the subacute toxicity of the EA ‐ergocryptine has been studied in rats and has been ascribed to interactions with the central dopaminergic system with a NOAEL of 4 mg/kg diet, amounting to about 0.2 mg/kg bw/day 127, 128. In another study, the subacute toxicity of ergometrine maleate was characterised in rats pointing at a NOAEL of 10 mg ergometrine maleate/kg diet equivalent to about 1 mg ergometrine maleate/kg bw/day corresponding to 0.74 mg ergometrine/kg bw/day 129. The authors of this study also indicated that the maximum concentration of EAs in rey, wheat and oats in The Netherlands was reported to amount to 2.36 mg/kg.…”
Section: Alkaloids Derived From Tryptophanmentioning
confidence: 99%